[EN] PAD4 INHIBITORS AND USE THEREOF [FR] INHIBITEURS DE PAD4 ET LEUR UTILISATION
摘要:
The present disclosure provides a compound represented by structural formula (I0) or a pharmaceutically acceptable salt, or a stereoisomer thereof and their use in, e.g. treating a disease or disorder associated with the PAD4 activity. This disclosure also features compositions containing the same as well as methods of using and making the same.
Asymmetric Hydrogenation of 2- and 2,3-Substituted Quinoxalines with Chiral Cationic Ruthenium Diamine Catalysts
作者:Jie Qin、Fei Chen、Ziyuan Ding、Yan-Mei He、Lijin Xu、Qing-Hua Fan
DOI:10.1021/ol2029096
日期:2011.12.16
The enantioselective hydrogenation of 2-alkyl- and 2-aryl-subsituted quinoxalines and 2,3-disubstituted quinoxalines was developed by using the cationic Ru(η6-cymene)(monosulfonylated diamine)(BArF) system in high yields with up to 99% ee. The counteranion was found to be critically important for the high enantioselectivity and/or diastereoselectivity.